Neon Therapeutics begins enrolment for inaugural trial of cancer vaccine NEO-PV-01

US-based immuno-oncology company Neon Therapeutics has begun enrolment for its inaugural trial of NEO-PV-01 to treat cancer.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news